[CAS NO. 1601496-05-2]  GSK-843

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1601496-05-2]

Catalog
HY-125402
Brand
MCE
CAS
1601496-05-2

DESCRIPTION [1601496-05-2]

Overview

MDL-
Molecular Weight377.49
Molecular FormulaC19H15N5S2
SMILESNC1=NC=C(C2=CC(C)=NN2C)C3=C1C(C4=CC=C(SC=N5)C5=C4)=CS3

For research use only. We do not sell to patients.


Summary

GSK-843 (GSK'843) is a receptor-interacting protein kinase 3 (RIP3 or RIPK3) inhibitor, which binds RIP3 kinase domain with an IC 50 of 8.6 nM, and inhibits kinase activity with an IC 50 of 6.5 nM. GSK-843 can be used for the research of inflammation [1] [2] .


IC50 & Target

IC50: 6.5 nM (RIP3) [1]


In Vitro

GSK-843 (3-10 μM; 18 h) induces apoptosis [1] .
GSK-843 (0.3-3 μM; 18 h) suppresses TNF-induced death and virus-induced cell necrosis [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay [1]

Cell Line: SVEC, L929, 3T3SA and mouse embryo fibroblast (MEF)
Concentration: 3 and 10 μM
Incubation Time: 18 hours
Result: Decreased the cell viability of SVEC, L929, 3T3SA and MEF cells, and induced caspase activation followed by apoptotic cell death.

Cell Viability Assay [2]

Cell Line: 3T3-SA and SVEC4-10 cells
Concentration: 0.3, 1 and 3 μM
Incubation Time: 18 hours
Result: Dose-dependently suppressed TNF-induced death and virus-induced necrosis to improved cell viability.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 50 mg/mL ( 132.45 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.6491 mL 13.2454 mL 26.4908 mL
5 mM 0.5298 mL 2.6491 mL 5.2982 mL
10 mM 0.2649 mL 1.3245 mL 2.6491 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: 4.8 mg/mL (12.72 mM); Suspended solution; Need ultrasonic

  • 2.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 2.08 mg/mL (5.51 mM); Clear solution

* All of the co-solvents are available by MCE.